Literature DB >> 28440670

Cardiac magnetic resonance based evaluation of aortic stiffness and epicardial fat volume in patients with hypertension, diabetes mellitus, and myocardial infarction.

Rami Homsi1, Alois M Sprinkart1, Juergen Gieseke1,2, Michael Meier-Schroers1, Seyrani Yuecel3, Stefan Fischer1, Jennifer Nadal4, Darius Dabir1, Julian A Luetkens1, Daniel L Kuetting1, Hans H Schild1, Daniel K Thomas1.   

Abstract

Background Aortic stiffness and epicardial fat relate to cardiovascular risk. Their relationship with each other and their role with hypertension, diabetes mellitus (DM), and myocardial infarction (MI) can be evaluated by cardiac magnetic resonance (CMR). Purpose To explore an association between aortic stiffness and epicardial as well as paracardial fat volume (EFV and ParaFV, respectively) in hypertensive patients and to relate the results to the presence of DM and MI. Material and Methods A total of 156 hypertensive and 20 non-hypertensive participants were examined at 1.5 Tesla. A 2D-velocity-encoded sequence was acquired to assess aortic pulse wave velocity (PWV in m/s) as a measure of aortic stiffness. A 3D-Dixon sequence was used to determine EFV and ParaFV. Results PWV correlated with EFV (R = 0.474; P < 0.001), but not with ParaFV. Fat volumes (in mL/m2) and PWV were lower in non-hypertensive controls compared to hypertensive patients. EFV and PWV were significantly higher in diabetic hypertensive patients without MI (n = 19; PWV: 10.4 ± 2.9; EFV: 92.5 ± 19.3) compared to hypertension-only patients (n = 84 [no DM or MI]; EFV: 64.8 ± 25.1, PWV: 9.0 ± 2.6; P < 0.05). Logistic regression analysis showed a significant association between the presence of a MI and a higher EFV ( P < 0.05), but not with PWV ( P = 0.060) or ParaFV ( P = 0.375). Conclusion A relationship between aortic stiffness and EFV was found in hypertensive patients. Both were increased in the presence of DM; however, only EFV was increased in the presence of MI. This may relate to the PWV lowering effect of the antihypertensive medication used by hypertensive patients and underscores the benefit of EFV assessment in this regard.

Entities:  

Keywords:  Epicardial fat; aortic stiffness; cardiac magnetic resonance; diabetes mellitus; hypertension; myocardial infarction

Mesh:

Year:  2017        PMID: 28440670     DOI: 10.1177/0284185117706201

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  4 in total

1.  Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes.

Authors:  Peter P Swoboda; Bara Erhayiem; Rachel Kan; Adam K McDiarmid; Pankaj Garg; Tarique A Musa; Laura E Dobson; Klaus K Witte; Mark T Kearney; Julian H Barth; Ramzi Ajjan; John P Greenwood; Sven Plein
Journal:  Cardiovasc Diabetol       Date:  2018-03-05       Impact factor: 9.951

2.  Quantification of epicardial fat using 3D cine Dixon MRI.

Authors:  Markus Henningsson; Martin Brundin; Tobias Scheffel; Carl Edin; Federica Viola; Carl-Johan Carlhäll
Journal:  BMC Med Imaging       Date:  2020-07-14       Impact factor: 1.930

3.  EAT Thickness as a Predominant Feature for Evaluating Arterial Stiffness in Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Zhiqiang Liu; Weiwei Hu; Hanwen Zhang; Hongmei Tao; Peng Lei; Jie Liu; Yali Yu; Qian Dong; Lei Gao; Dongying Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-21       Impact factor: 3.168

Review 4.  Effects of antidiabetic drugs on epicardial fat.

Authors:  Eleni Xourgia; Athanasia Papazafiropoulou; Andreas Melidonis
Journal:  World J Diabetes       Date:  2018-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.